Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut

Medtronic's diabetes unit MiniMed valued at $5.3 billion as shares fall in Nasdaq debut | ReutersSkip to main contentExclusive news, data and analytics for financial market professionalsLearn more aboutRefinitivA screen displays MiniMed signage during the company's IPO at the Nasdaq MarketSite in New York City, U.S., March 6, 2026. REUTERS/Heather Khalifa Purchase Licensing Rights, opens new tab- CompaniesMedtronic IncFollowMedtronic PLCFollowMiniMed Group IncFollowMarch 6 (Reuters) - Shares of MiniMed (MME ...